SELIGMAN PRIVATE EQUITY SELECT
SELIGMAN PRIVATE EQUITY SELECT is a Series C+, secondary and buyout fund in Europe investing in Healthcare and life-science.
- Stages
- Series C+, secondary, buyout
- Sectors
- Healthcare, life-science
- Invests in
- Europe
- Founded
- 2003
Check size not disclosed
Thesis
Seligman Private Equity Select is an independent, employee-owned private equity firm based in London, established in 2003. It specializes in providing liquidity solutions, primarily through secondary transactions, for European companies. The firm acquires existing shares from management, founders, or early investors, and also invests in new shares to provide late-stage growth capital, operating as a passive minority investor. While focusing on various sectors across Western Europe, there's a noted interest in Biotech/life science. They have completed over 50 transactions into 94 companies, largely through their General Partner network. The firm has launched six funds, including primary fund-of-funds with secondary components and dedicated liquidity solutions funds. Their European Secondary Opportunities II fund (2014) raised €80 million and delivered a 1.6x return multiple. The debut secondaries fund (2010) delivered 2.5x cost. The firm's AUM is over €300 million. They were formerly the captive fund investment unit of the European financial house Edmond de Rothschild Group before becoming independent.
Common questions
Does SELIGMAN PRIVATE EQUITY SELECT invest at the Series C+ stage?
Yes. SELIGMAN PRIVATE EQUITY SELECT lists Series C+, secondary and buyout among the stages it invests in.
Where does SELIGMAN PRIVATE EQUITY SELECT invest?
SELIGMAN PRIVATE EQUITY SELECT invests in Europe.